TippingPoint Biosciences has raised $4.5M in a Seed round led by SOSV and LKS Fund to develop pioneering therapies for pediatric brain cancer.
Amount Raised
$4.5 Million
Round Type
Seed
San FranciscoBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
TippingPoint Biosciences announced the closing of an oversubscribed $4.5 million seed financing for a breakthrough drug discovery platform. This platform targets epigenetic protein interfaces considered 'undruggable,' advancing precision medicine for pediatric cancers. The funding was led by SOSV and LKS Fund with contributions from other notable investors. The company aims to unlock new therapy targets for complex diseases.
Quick answer
TippingPoint Biosciences raised $4.5 Million in a Seed round, dated March 31, 2026. Investors: Storyhouse Ventures, American Cancer Society BrightEdge, WeCAN, Xeia, Sazze Partners, Freeflow Ventures, Sontag Innovation Fund and We Can. TippingPoint Biosciences is based in San Francisco, California, United States.
- How much did TippingPoint Biosciences raise?
- TippingPoint Biosciences raised $4.5 Million in a Seed round on March 31, 2026.
- Who invested in TippingPoint Biosciences?
- Storyhouse Ventures, American Cancer Society BrightEdge, WeCAN, Xeia, Sazze Partners, Freeflow Ventures, Sontag Innovation Fund and We Can are named as investors in this round.
- What does TippingPoint Biosciences do?
- TippingPoint Biosciences is a San Francisco-based therapeutic company focused on innovative drug discovery targeting the aberrant DNA in cancer cells.
- Where is TippingPoint Biosciences based and how big is it?
- TippingPoint Biosciences is based in San Francisco, California, United States.
- Who are the decision-makers at TippingPoint Biosciences?
- Fundz holds 1 contact at TippingPoint Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as TippingPoint Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
- Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
- Diamyd Medical raised $125M (Funding Round) on March 23, 2026.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
Who to call at TippingPoint Biosciences, and when
A new round usually means TippingPoint Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TippingPoint Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TippingPoint Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TippingPoint Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TippingPoint Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TippingPoint Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.